Light grey background with one-third of the Atomo circle in dark grey on the right hand side and a series of dark grey dots in the top right-hand corner

Respiratory Test

Lumos Diagnostics partnered with Atomo to develop a novel, rapid, point-of-care test that differentiates between viral versus bacterial acute respiratory infection in 10 minutes.

FebriDx Antimicrobial Resistance (AMR) Screening Test

FebriDx Antimicrobial Resistance (AMR) Screening Test
Test platform designed & manufactured by Atomo; Branded & Distributed by Lumos
Sold in Europe and under review with the US FDA
authorised to identify and differentiate viral from bacterial acute respiratory infection. With 99% accuracy, this test has reduced antibiotic prescriptions by 80%, leading to better efficiencies and lower costs.

White plastic cassette with green tipped lancet.

Finished rapid test products are commercialised under Atomo's own brand or under private labels via partners and regional distributors. We hold regulatory approvals including CE Mark in the EU/ UK, Australian TGA, and the World Health Organization with FDA approvals pending.

Develop Future Tests With Us

Atomo’s unique technology presents an opportunity to improve existing products on the market with superior usability. Our integrated platforms can help users easily perform the tests on their own and improve performance, speed and reliability in a professional clinical setting.

We welcome dialogue with forward-thinking diagnostic partners who would like to explore co-developing tests for infectious diseases, allergy sensitivities, women’s health, men’s health, sexual health, heart health and other applications.

Man and woman sitting at desk looking at diagnostic test design on computer screen
Smiling woman leaning on the back of a smiling man in an outdoor setting with trees in the background

Re-imagining diagnostics.